Induction of Apoptosis in the Murine Liver With Recombinant Human Activin A
Open accessThe DOI matches its Crossref record.
Abstract
Recombinant human activin A, a member of the transforming growth factor–β superfamily, induced significant cell loss in rodent livers and in primary hepatocyte cultures. Histologically and biochemically the hepatocyte death was mediated by apoptosis, a form of programmed cell death. Male mice were treated with 200 or 500 μg recombinant human activin A/kg body wt/day for up to 3 days by means of a subcutaneously implanted minipump. Livers were taken for light and electron microscopy, DNA isolation and in situ nick end–labeling. Primary cultures of rat hepatocytes were treated with 10 ng/ml recombinant human activin A for 24 hr before being harvested for electron microscopy and DNA isolation. Infusion of activin A evoked dose–dependent loss of liver mass due to the atrophy and death of hepatocytes around the central vein. Morphologically, the dying cells demonstrated all the characteristic nuclear and cytoplasmic features of apoptosis. Low molecular weight DNA isolated activin A—treated intact livers and primary cultures exhibited the typical oligosomal ladder. Nick end–labeling of DNA in situ confirmed that virtually all topographical apoptotic hepatocytes had fragmented DNA. The currently accepted criteria for apoptosis (i.e., specific morphological alterations and internucleosomal clipping of DNA) were evident in activin A—treated hepatocytes both in vitro and in vivo , leading to the conclusion that cell loss occurs mainly through apoptosis. These observations suggest that activin A may be important in hepatic homeostasis. (Hepatology 1994;20:854-861).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Mammalian Ovary from Genesis to Revelation
Edson, M. A., Nagaraja, A. K., & Matzuk, M. M. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0012 · Cited by 820
Roles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
Roles of TGF-beta in hepatic fibrosis
Gressner, A. (2002) · Frontiers in Bioscience · doi:10.2741/gressner · Cited by 405
Regulation of liver regeneration by growth factors and cytokines
Böhm, F., Köhler, U. A., Speicher, T., & Werner, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000085 · Cited by 278
Roles of activin in tissue repair, fibrosis, and inflammatory disease
WERNER, S., & ALZHEIMER, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.001 · Cited by 209
Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins
Leist, M., Gantner, F., Naumann, H., Bluethmann, H., Vogt, K., Brigelius-Flohe, R., Nicotera, P., Volk, H., & Wendel, A. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041255 · Cited by 204
Aykul, S., & Martinez-Hackert, E. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713487 · Cited by 143
“Human BMPRII (Q13873) and TGF RII (P37173) were cloned from cDNA (Open Biosystems) and fused to IgG1-Fc by PCR. Receptor-Fc fusion constructs included signal peptide and extracellular domains of human ActRIIA(1–120), ActRIIB(1–120), TGF RII(1–166), or BMPRII(1–136).”
BackgroundInfluentialClinical and therapeutic implications of follistatin in solid tumours
SHI, L., RESAUL, J., OWEN, S., YE, L., & JIANG, W. G. (2016) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20005 · Cited by 47
Walton, K. L., Chen, J. L., Arnold, Q., Kelly, E., La, M., Lu, L., Lovrecz, G., Hagg, A., Colgan, T. D., Qian, H., et al. (2019) · Endocrinology · doi:10.1210/en.2019-00257 · Cited by 23
“blocking activin-mediated apoptosis of hepatocytes and the resulting loss of liver mass (33).”
Background
Metadata
- Authors
- Hully, J. R., Chang, L., Schwall, R. H., Widmer, R. H., Terrell, T. G., & Gillett, N. A.
- Venue
- Hepatology
- Published
- 1994-10
- Volume
- 20
- Issue
- 4
- Pages
- 854-862
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2008461201
- Cited by
- 118
- References
- 0
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.